RECURSION PHARMACEUTICALS, INC. - 10-Q Filing
Recursion Pharmaceuticals reports third quarter 2026 results and discloses subsequent public offering on October 16, 2026
Tickers: $RXRX
More Regulatory news
- Applied Aerospace & Defense, Inc. - 10-Q Filing
- Palomar Holdings, Inc. - 8-K Filing
- UNITED GUARDIAN INC - 10-Q Filing
- Dare Bioscience, Inc. - 8-K Filing
- NEXGEL, INC. - 8-K Filing
- TEREX CORP - 8-K Filing
- Victory Capital Holdings, Inc. - 8-K Filing
- Nano Dimension Ltd. - 8-K Filing
- M-tron Industries, Inc. - 10-Q Filing
- M-tron Industries, Inc. - 8-K Filing